Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Coronary DiseaseHeart DiseasesCardiovascular DiseasesNeurologic Manifestations
Interventions
DRUG

Magnesium

100 mg/kg

DRUG

0.9% saline

Placebo

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Duke University

OTHER